Mar 19, 2026 · Senate
Committee on Health, Education, Labor, and Pensions. Hearings held.
S. 297 · Senate · Introduced Jan 29, 2025
Sponsored by John Boozman (R, AR)
- INTRODUCED
- COMMITTEEMar 19, 2026
- PASSED SENATE
- HOUSE
- LAW
In committee. Latest action on Mar 19, 2026: Committee on Health, Education, Labor, and Pensions. Hearings held. It has 6 cosponsors and 3 recorded actions, and 3 organizations cited it in Q2 2026 lobbying disclosures.
Recent actions
3 totalJan 29, 2025 · Library of Congress
Introduced in Senate
Jan 29, 2025 · Senate
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Reported lobbying
3
organizations cited S. 297 in a lobbying disclosure
Q2 2026 · the most recent completed reporting period you can see
| Organization | Filed by | Total Q2 2026 lobbying |
|---|---|---|
| American Cancer Society Cancer Action Network | In-house | $1,240,000 |
| Astellas Pharma US | In-house | $510,000 |
| Dana-Farber Cancer Institute | In-house | $36,000 |
These totals are not spending on this bill. Lobbying is reported per filing, not per issue — each figure is everything the organization reported for the period, across every bill and agency it named. Read it as scale of presence.
Latest activity
Lobbying reported · American Cancer Society Cancer Action Network · Jul 20
American Cancer Society Cancer Action Network reported 2nd Quarter (Apr 1 - June 30) lobbying for American Cancer Society Cancer Action Network — $1,240,000
BillsH.R. 140H.R. 247H.R. 1300H.R. 1406H.R. 1834H.R. 2319H.R. 2381H.R. 2528H.R. 2571H.R. 3037H.R. 3521H.R. 3873H.R. 4184H.R. 4417H.R. 4425H.R. 4541H.R. 5145H.R. 5269H.R. 5328H.R. 5439H.R. 5509H.R. 6178H.R. 6280H.R. 6423H.R. 6501H.R. 6561H.R. 6575H.R. 6845H.R. 7790H.R. 8358H.R. 8783H.R. 8839H.Res. 1196S. 46S. 297S. 864S. 1157S. 1500S. 1847S. 1866S. 2064S. 2339S. 2761S. 2771S. 2793S. 2834S. 2903S. 2927S. 3569S. 4318S. 4440S. 4494S. 4511S. 4717
You’re all caught up.